Myrica-75 mg Capsule

Marketed by Unimed Unihealth Pharmaceuticals Ltd, Myrica-75 provides 75 mg of pregabalin in capsule form. This gabapentinoid is well established for the treatment of neuropathic pain and for the add-on control of partial-onset seizures.

Myrica-75 75 mg capsule is manufactured and marketed by Unimed Unihealth Pharmaceuticals Ltd. in Bangladesh. It contains Pregabalin, a strictly prescription-only medicine for nerve (neuropathic) pain — such as diabetic neuropathy and pain after shingles — as well as fibromyalgia, certain types of epilepsy and generalised anxiety disorder. It is not an ordinary painkiller and does not help routine aches; misuse of pregabalin without prescription has become a serious problem in Bangladesh.

Pregabalin works by binding to a subunit of calcium channels on overactive nerve cells, reducing the release of excitatory chemical messengers. This calms abnormal nerve firing, which eases burning, shooting or electric-shock-like nerve pain, reduces seizures and lowers anxiety. Benefits build gradually over days to weeks rather than within hours.

Myrica-75 is prescribed for:

• Neuropathic pain — diabetic peripheral neuropathy, post-herpetic neuralgia (pain after shingles), nerve pain from spinal cord injury, sciatica-type nerve pain when a specialist advises
• Fibromyalgia — widespread body pain with fatigue and sleep problems
• Epilepsy — as add-on treatment for partial (focal) seizures
• Generalised anxiety disorder — under psychiatric supervision

It must be used only for a doctor-confirmed diagnosis. It does not work for ordinary headaches, muscle pain or arthritis, and self-medication risks dependence.

ChamberBD shows dosing only from the approved product label, with its source named, and no label is on file for Myrica-75 mg Capsule. Use the dose your doctor prescribed and the instructions in the pack leaflet.

Common side effects of Myrica-75, especially in the first weeks:

• Dizziness and sleepiness — the most frequent; often settle with time
• Unsteadiness, blurred vision, poor concentration
• Weight gain and increased appetite
• Swelling of hands, ankles or feet
• Dry mouth, constipation
• Mood changes; rarely, depressed mood or suicidal thoughts — report these immediately

Serious but uncommon: severe allergic swelling of face or tongue, breathing difficulty (especially combined with opioids or other sedatives), and dependence with withdrawal symptoms (insomnia, anxiety, sweating, seizures) if stopped abruptly.

Essential precautions with Myrica-75:

• Take it only on a doctor's prescription, for the diagnosed condition — pregabalin is widely misused in Bangladesh and causes real dependence
• Never stop abruptly; taper over at least a week as your doctor directs
• Avoid driving, riding motorbikes or operating machinery until you know how drowsy it makes you
• Do not drink alcohol and do not combine with sleeping pills or opioid painkillers without medical advice — breathing can be dangerously suppressed
• Tell your doctor about kidney disease, heart failure, breathing problems, mood disorders or any history of substance misuse
• Watch weight and ankle swelling; diabetics should monitor glucose and foot skin
• Keep it securely away from others — never share

Important interactions of Myrica-75:

• Opioid painkillers (tramadol, morphine, codeine) — combined sedation and dangerous breathing suppression; use together only under close medical supervision
• Benzodiazepines and sleeping pills (clonazepam, diazepam, zolpidem) — additive drowsiness and respiratory depression
• Alcohol — markedly increases sedation and accident risk; avoid completely
• Antihistamines and other sedating medicines — added drowsiness
• Pioglitazone and similar diabetes medicines — increased fluid retention and weight gain
• ACE inhibitors — possible higher risk of facial swelling (angioedema)

Pregabalin has few interactions through liver enzymes, but its sedative combinations are the real danger — tell your doctor everything you take.

Do not take Myrica-75 if you have:

• Known allergy to pregabalin or any ingredient of the product

Use it only with special caution and specialist advice if you have:

• Significant kidney impairment (dose must be reduced)
• Severe breathing problems or you take opioids/sedatives
• A history of drug or alcohol misuse — dependence risk is higher
• Severe heart failure
• Rare hereditary problems of galactose intolerance (capsules may contain lactose)

It is not approved for routine use in children outside specialist epilepsy care.

Pregnancy: Myrica-75 should be avoided in pregnancy unless clearly necessary. Studies suggest a slightly increased risk of birth defects when taken in the first trimester, so women planning pregnancy should discuss alternatives, and effective contraception is advised during treatment. Never stop it abruptly on discovering pregnancy — contact your doctor for a safe plan.

Breastfeeding: Pregabalin passes into breast milk, and its effects on the baby are not well established; it is generally not recommended while breastfeeding. Discuss the safest option with your doctor.

Store Myrica-75 below 30°C in a dry place, away from light and moisture, in the original pack. Because pregabalin is a medicine with misuse potential, keep it securely stored and strictly out of the reach of children and others — never leave strips lying around or share them. Do not use after the expiry date on the pack.